 |
You must be logged in to post comments on this site - please either log in or if you are not registered click here to signup
I was diagnosed hiv positive in 1999, my cd4 in June was 150, i found tabs on the net called REVIVO im currently on them for a month now and my cd4 has increased to 250, this web site has people claiming they have a cure for R10000, -link- somebody tell me what is you take on this
We believe that the MCTS: Windows Vista papers will help you pass the certification exam without failure, because it is the most updated and precise free test questions!there are some MCITP Certification.
If the <a href="http://www.exa mshots.com">free IT certification test questions</a> waste you much time and effort? Getting the <a href="http://www.70- 680.com">MCTS Certification, which <a href="http://www.mci tp-70-620.com">MCTS: Windows Vista</a> help the <a href="http://www.mci tp-70-680.com">MCITP Certification IT professionals all over the world pass the<a href="http://www.apl us-220-701.com">Comp TIA easily and fastly, to get your success!
Everybody knows that Oracle [url= http://www.examshots.com]free certification practice questions[/url] training practice is very important to the candidates for the preparation of certification exams. But it is very inconvenience to take Oracle [url= http://www.examshots.com/vendor/CompTIA-4.html]free CompTIA questions[/url] training practice in a classroom. Candidates who cannot attend the classroom sessions shall select online training through various websites. It is very easy for the candidates to find the best Oracle [url= http://www.mcts-70-620.com]MCTS: Windows Vista[/url] exam question information in Exambible’s rich Oracle [url= http://www.70-680.com]MCTS: Windows 7, Configuration[/url] study guide sources. All 1z0-043 test candidates can make use of the facility and prepare for the Oracle [url= http://www.mcitp-70-620.com]MCTS: Windows Vista[/url] real exam.
Hello, to any single lady w/HIV+ living in Canada country, My name is Henry living in Kenya, I'm a good looking 34yrs.old BLK. man. I've now been Pos. for 6yrs. I'm Looking for a female friend who might be HIV Pos, that would like to be along term friend,marry,exchange ideas,photos,ready to support, or have coffee, or just talk and help other living positive! The age doesn't matter!!!!my adress is henryodu@yahoo.com
<a href=http://www.elux uryinn.com/products/ Louis-Vuitton-Ursula -White-M40123-17480. html>Louis Vuitton Ursula White M40123 On Sale</a>
<a href=http://www.loui s-vuitton-sale.org/l ouis-vuitton-wallet/ louis-vuitton-wallet .html>Louis Vuitton Wallet</a>
<a href=http://www.elux uryinn.com/products/ Louis-Vuitton-Mini-H L-M92645-18965.html> Louis Vuitton Mini HL M92645 On Sale</a>
its just amatter settling your mind.
<A href="http://www.iof feritems.com/">Cheap Nike Air Force One shoes</A>
<A href="http://www.iof feritems.com/">Cheap Nike Air Force 1 shoes</A>
<br /> <A href="http://www.iof feritems.com/">Cheap Nike Air Max shoes</A>
<A href="http://www.iof feritems.com/">Cheap Nike Air Max Tn shoes
<A href="http://www.iof feritems.com/">Cheap Nike Air Rift shoes</A>
<A href="http://www.iof feritems.com/nike-du nk-sb.html">Cheap Nike Dunk SB</A><br />
<A href="http://www.iof feritems.com">Cheap Nike Shox shoes</A> <br />
<em><a href="http://www.iof feritems.com">Cheap nike <a href="http://www.iof feritems.com">Cheap jordan shoes</a>
|
|
|
|
Welcome to LivingPositive.org
The vision is to create a One Stop News, Health, and Services Database for the HIV community. This site is completely interactive. So, as a community, we can come together and collectively help each other locate important News, Services, and Friendships.
Most of us know, or remember, the fear that a simple dental appointment can trigger. Personally, I still feel a little uneasy just getting a haircut. Many of us have gone for years without basic health care necessities simply because we fear the unknown. Let’s end that fear and at the same time support the people in our communities who have supported us.
The concept is simple and the possibilities are limitless. Read a good article; post it. Know a good doctor, dentist, pharmacist, hair stylist, or massage therapist; post it. Anything that you find important, or think someone else will find important; post it.
Together, we can make a difference.
Sincerely,
LivingPositive.org
|
|
|
Infants infected with HIV who are treated with one or two antiretroviral drugs within two months of birth are less likely to develop AIDS by their third birthdays than infants who are treated later, according to a new study conducted by researchers at Stanford’s School of Medicine and the Lucile Packard Children’s Hospital. Babies who received a cocktail of three antiretroviral drugs fared even better. The results are significant because there is still some uncertainty about potential side effects when drugs are administered at a very young age.
“There is a significant difference in the likelihood of disease progression, even though there is only about a month separating the initiation of therapy in the two groups,” said[censored]ociate Prof. of Pediatrics Yvonne Maldonado, the report’s senior author.
Currently, deciding when to begin treating an HIV-infected infant is the responsibility of the child’s physician, largely because the long-term effects of ongoing retroviral treatment are unknown.
“The whole idea of the study is to follow children with HIV over time and make sure we could track the illness in children, then to use that tracking to make sure we could treat children better and more effectively,” Maldonado said.
Without treatment, about 20 to 30 percent of infected infants will develop AIDS by the time they reach four months old. The rest will develop advanced symptoms by the time they are six years old.
Since some of these infected infants will appear healthy, researchers suggest that early treatment might be appropriate for even those who do not show symptoms of the disease. However, they caution that clinical trials are needed to determine if every infected newborn should be treated or if some infants will benefit more than others.
Maldonado and her colleagues collected data from hospitals throughout northern California over a 17-year period beginning in 1988. They followed the children for the first three years of life, tracked their age when AIDS developed and the rate of survival through their third birthdays.
“We were able to analyze children with the full-spectrum of disease across many years, rather than using mathematical models to predict the development of illness in the children,” Maldonado said. “We were able to see the real distribution of illness, what kinds of treatment the children were given and the ages when they started treatment.”
The researchers divided the newborns into three groups: those born between 1988 and 1991, between 1992 and 1995 and between 1996 and 2001 based on the types of therapy available in those years. Members of the early group were tested for infection by their first birthday; members of the middle and late groups were[censored]essed within the first month, and those in the late group benefited from the introduction of a special type of antiretroviral drug called a protease inhibitor, which interferes with the virus’ ability to replicate.
Not surprisingly, infants born later were more likely to receive triple-drug therapy and less likely to experience symptoms of AIDS. In fact, none of the 23 children who received triple-drug therapy developed AIDS before their third birthdays and none died.
“This is an important finding because there’s been a lot of controversy in the literature as to whether infected but asymptomatic infants should be started on therapy right away,” Maldonado said. “We’ve clearly shown that early treatment of asymptomatic infants — no matter what it is — makes a big difference in preventing or delaying the progression of the disease.”
|
|
|
Roche says to pull older HIV drug on poor demand
|
|
|
|
|
Roche Holding AG said on Wednesday it will voluntarily withdraw its anti-HIV drug Fortovase in early 2006 because demand for the drug has declined significantly.
The Swiss drugmaker said Fortovase will be discontinued in the first quarter of 2006 because of the availability of a new formulation of the drug, sold as Invirase, which is easier to tolerate.
Roche said the decision was not a result of concerns about safety or effectiveness. Roche said its drug Invirase will remain on the market.
|
|
|
|
No events for this month.
|
|
|
